CA2560253C — Prodrugs of piperazine and substituted piperidine antiviral agents
Assigned to ViiV Healthcare UK No 4 Ltd · Expires 2013-01-15 · 13y expired
What this patent protects
This invention provides for prodrug Compounds (I), pharmaceutical compositions thereof, and their use in treating HIV infection. Also, this invention provides for intermediate Compounds (II) useful in making prodrug Compounds (I).
USPTO Abstract
This invention provides for prodrug Compounds (I), pharmaceutical compositions thereof, and their use in treating HIV infection. Also, this invention provides for intermediate Compounds (II) useful in making prodrug Compounds (I).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.